IM Cannabis (IMCC) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$1.42

$1.73

Volume / Avg.

932.67K / 505.66K

Day Range

$1.41 - $1.75

52 Wk Range

0.93 - 7.12

Market Cap

$8.92M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.7%

Days to Cover

Recent IM Cannabis Corp News

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations

This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.

Javier Hasse

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3

International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). "While the 66% growth we delivered in Germany, to reach $5.8M this quarter is a highlight, we spent the quarter focused on building a solid foundation for 2025," Oren Shuster, the company's CEO, said. "Our goal was to build a strong, consistent supply chain, along with a laser focus on how to improve the efficiency and accuracy of how we use our resources. I believe that the foundation we built this quarter will be the basis we will use to deliver in 2025."

Jelena Martinovic

Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) a medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter ended Sept. 30 on Nov. 14, 2024, before the market opens. Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) will report earnings results for its third quarter ended Sept. 30 on Friday, Nov. 8, 2024, before the financial markets open.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

$1.42

$1.73

Volume / Avg.

932.67K / 505.66K

Day Range

$1.41 - $1.75

52 Wk Range

0.93 - 7.12

Market Cap

$8.92M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.7%

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry